Skip to main content

Table 1 Baseline Demographics and Clinical Data of the Two Groups

From: Comparison of 27-gauge beveled-tip and 25-gauge flat-tip microincision vitrectomy surgery in the treatment of proliferative diabetic retinopathy: a randomized controlled trial

 

27G beveled-tip

(n = 25)

25G flat-tip

(n = 22)

p value

Age (year)

52.2 ± 12.0

52.6 ± 8.7

0.906*

Male sex

12(48%)

12(54.5%)

0.503†

HbA1c (%)

7.9 ± 1.2

7.7 ± 1.5

0.544*

Duration of DM (year)

10 (10, 20)

10 (10, 20)

0.961ǂ

Grade

  

0.509†

I

II

III

IV

Macula involved

2 (8.0%)

10 (40.0%)

11 (44.0%)

2 (8.0%)

12 (54.5%)

4 (18.2%)

9 (40.9%)

6 (27.3%)

3 (13.6%)

10 (45.5%)

0.861†

Number of retinal detachments

19 (76.0%)

15 (68.2%)

0.550†

Lens status

  

1.000†

Phakic

Pseudophakic

Aphakic

23 (92.0%)

2 (8.0%)

0 (0%)

21 (95.5%)

1 (4.5%)

0 (0%)

 

Preop BCVA (logMAR)

1.53 ± 0.49

1.68 ± 0.66

0.651*

Preop IOP (mmHg)

15.5 ± 3.2

16.4 ± 4.0

0.376*

Number of preop IVI Anti-VEGF treaments

17 (68.0%)

16 (72.7%)

0.724†

Number of preop PRP

2 (8.0%)

3 (13.6%)

0.880†

  1. *Based on t-test; †based on chi-square test/Fisher’s exact test; ǂbased on Mann–Whitney U test.
  2. 27G, 27-gauge; 25G, 25-gauge; HbA1c, hemoglobin A1c; preop, preoperative; DM, diabetes mellitus; BCVA, preoperative best-corrected visual acuity; logMAR, logarithm of the minimal angle of resolution; IOP, preoperative intraocular pressure; IVI, intravitreal injection; Anti-VEGF, anti-vascular endothelial growth factor; PRP, panretinal photocoagulation.